Mon Health Heart & Vascular Center Wins HeartFlow CT Quality Award in 2nd Quarter of 2022

Posted Date: 9/14/2022

Mon Health Heart & Vascular Center announced today that it has earned the HeartFlow CT Quality Award in the 2nd quarter of 2022. Recipients of the HeartFlow CT Quality Award are determined based on metrics assessing the quality and adoption of a medical center’s cardiovascular imaging program.

Recipients of the award are in the top 20% of global medical centers providing patients with a better pathway for identifying and understanding their heart health by utilizing CAT scans of the heart arteries and the HeartFlow Analysis. The HeartFlow Analysis is a first-of-its-kind non-invasive technology to aid physicians in the diagnoses of coronary artery disease (CAD), the most common form of heart disease.

“This achievement is validation that Mon Health Heart & Vascular Center is leading the way in providing innovative and effective treatment for our patients,” said Dr. Bradford Warden, Executive Director and Interventional Cardiologist of Mon Health Heart & Vascular Center. “We recognize and thank our dedicated heart and vascular team for improving the heart health of the communities we serve, one patient at a time.”

The HeartFlow Analysis takes data from a patient’s non-invasive coronary CTA and leverages algorithms trained using deep learning (a form of AI) and highly trained analysis to create a personalized, digital 3D model of the patient’s coronary arteries. It then uses powerful computer algorithms to simulate blood flow and assess the impact of blockages on blood flow to the heart. Within hours, the HeartFlow Analysis is provided to the patient’s physician via a secure web interface and provides information on the extent of a patient’s arterial blockage and the impact the blockage has on blood flow to the heart.

The HeartFlow Analysis has been used for more than 100,000 patients with suspected heart disease and offers the highest diagnostic accuracy available from a non-invasive test. Additionally, in clinical trials, using the HeartFlow Analysis helped identify which patients do and do not need invasive treatment. The use of the HeartFlow Analysis also reduced the cost of care by 26% compared to usual care.

To learn more about Mon Health Heart & Vascular Center, visit MonHealth.com/Heart.

Back